HACKENSACK, N.J. (AP) — HACKENSACK, N.J. (AP) — Protalix BioTherapeutics Inc. (PLX) on Wednesday reported earnings of $18.3 million in its first quarter.
On a per-share basis, the Hackensack, New Jersey-based company said it had profit of 22 cents.
The drug developer posted revenue of $33.8 million in the period.
Protalix expects full-year revenue in the range of $78 million to $83 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PLX at https://www.zacks.com/ap/PLX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
